Niagen Bioscience Inc (NAGE)
Niagen Bioscience Inc. is a common stock listed on the NASDAQ exchange under the ticker NAGE. The company is a bioscience business focused on healthy aging products and operates across three segments: Consumer products, Ingredients, and Pharmaceutical. It develops and commercializes proprietary ingredient technologies, including food-grade and pharmaceutical-grade Niagen, and supplies these ingredients to manufacturers of consumer products as raw materials. Niagen Bioscience also sells finished dietary supplement products containing its proprietary ingredients directly to consumers and distributors. Its flagship ingredient is nicotinamide riboside, marketed under the NIAGEN brand, which is used in products such as TRU NIAGEN. The company distributes TRU NIAGEN through its e-commerce platform, Amazon, other online marketplaces, specialty retailers, and authorized healthcare practitioner resellers. Formerly known as ChromaDex Corporation, the company adopted the Niagen Bioscience name in March 2025 and is headquartered in Los Angeles, California.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-NAGE
|
$3.80
|
30.2% Upside
|
Undervalued
|
$12.08
|
313.8% Upside
|
Bargain
|
Great
|
0.0%
|
November 4, 2026
|
14.5x
|
2.8x
|
1.8x
|
231.5 M
|
167.3 M
|
1.0%
|
74.5%
|
6.1
|
35.5%
|
